Abstract
Carcinoma of the hypopharynx is a difficult disease to treat. Most patients on presentation have a few symptoms but have advanced stage of disease, often with cervical lymphadenopathy resulting in poor prognosis. Besides, airway and nutritional status are other important issues. Nearly 60–80% of patients are diagnosed to have stage III or IV disease at presentation [1–3]. Besides the high incidence of lymph node metastasis, another factor which contributes to poor prognosis is the significant rates of distant metastasis [4]. Nearly 60–80% patients of hypopharyngeal cancer present with clinically palpable nodal metastasis and often in contralateral neck. The distant metastasis may be seen in up to 40% and 60% cases [5]. Predominant sites for distant metastasis are the lung, mediastinal lymph nodes, liver and bone (Fig. 10.1a, b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hall SF, Groome PA, Irish J, O’Sullivan B. The natural history of patients with squamous cell carcinoma of hypopharynx. Larygngcope. 2008;118:1362–72.
Bahadur S, Amalya RC, Iyer S, et al. Study of distribution of cervical lymph node metastasis in squamous cell carcinoma of head and neck. Indian J Cancer. 1983;20:142–6.
Bahadur S, Kacker SK. Surgical treatment of pyriform fossa cancer. Indian J Otolaryngol. 1985;37:83–5.
Gourin CG, Terris DJ. Carcinoma of the hypopharynx. Surg Oncol Clin N Am. 2004;13:81–98.
Kotwalk C, Sako K, Razack MS, et al. Metastasis Patterns in squamous cell carcinoma of head and neck. Am J Surg. 1987;154:439–224.
Takas RP, Strigan P, Silver CE, Bradley PK, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;2:270–81.
Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by trans oral laser microsurgery in pyriform sinus carcinoma. Otolaryngol Head Neck Surg. 2001;124:58–67.
Lefebvre IL, Chevtiar D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst. 1996;88:890–8.
Buckley JG, MacLennan K. Cervical lymph node metastasis in laryngeal and hypopharyngeal cancer a prospective analysis of prevalence and distribution. Head Neck. 2000;22:380–5.
Wei WI. The dilemma of treating hypopharyngeal carcinoma: more or less. Arch Otolaryngeal Head Neck Surg. 2002;128:229–32.
Richman ID, Samji HA, Deschler DG. National laryngopharyngectomy and reconstructive surgery survival. Laryngoscope. 2009;119:1472–8.
Cusumano R, Silver C, Brauer R, Strauch B. Pectoralis myocutaneous flap for replacement of cervical oesophagus. Head Neck. 1989;11:450–6.
Lam K, Wei V, Lan V. Avoiding stenosis in tubed greater pectoral flap in pharyngeal repair. Arch Otolaryngol Head Neck Surg. 1996;83:1279–83.
Jones, AS, Roland NJ, Husband D, Hamilton JW, Gati I. Free revascularized jejunal loop repair following total pharyngolaryngectomy for carcinoma of the hypopharynx: Report of 90 patients. Br J Surg. 1996;83:1279–1283.
Rob GL, Larin J, Deschler DG, et al. Speech and swallowing outcomes in reconstruction of the pharynx and cervical esophagus. Head Neck. 2003;25:232–44.
Clark JR, Gilbert R, Irish J, et al. Morbidity after flap reconstruction of hypopharyngeal defects. Laryngoscope. 2006;116:173–81.
Bahadur S, Chatterjee TK. Repair of pharyngeal defect following pharyngolaryngectomy with special reference to gastric transposition. Indian J Otolaryngol. 1988;40:100–2.
Ogura JH, Marks JE, Freeman RB. Results of conservation surgery for supraglottic and pyriform sinus cancer. Laryngoscope. 1980;90:591–600.
Laccourreye O, Merite Drancy A, Brasnu D, et al. Supracricoid hemilaryngopharyngectomy in select pyriform sinus carcinoma staged T2. Laryngoscope. 1993;103:1373–9.
Laccourreye O, Ishoo E, de Mones E, et al. Supracricoid hemilaryngectomy pharyngectomy in patients with squamous cell carcinoma of the pyriform sinus. Ann Otol Rhinol Laryngol. 2005;114:25–34.
Ferlito A, Silver CE, Doward DJ, et al. Role of partial laryngeal cancer. Acta Otolaryngol. 2000;120:456–65.
Chevalier D, Watelet JB, Darras JA, Piquet JJ. Supraglottic hemilaryngectomy plus radiation for treatment of early lateral margin and pyriform sinus carcinoma. Head Neck. 1997;19:1–5.
Zeital SM, Koufman JA, Davis RK, et al. Endoscopic treatment of supraglottic and hypopharynx cancer. Laryngoscope. 1994;104:71–8.
Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by trans oral laser microsurgery in pyriform sinus cancer. Otolaryngol Head Neck Surgery. 2001;124:58–67.
Martin A, Jacket MC, Christiansen H, et al. Organ preservation with transoral laser microsurgery for cancer of hypopharynx. Laryngoscope. 2008;118:398–402.
Tandon DA, Bahadur S, Chatterjee TK, Rath GK. Carcinoma of the hypopharynx. Result of combined therapy. Indian J Cancer. 1991;28:131–8.
Jones AS. Surgery for hypopharyngeal cancer. In: Gleason M, editor. Scott-Brown otorhinolaryngology head and neck surgery, vol. 2. London: Hodder Arnold; 2008. p. 2633–62.
Vargees BT, Sebastian P, Mathew A. Treatment outcome in patients undergoing surgery for carcinoma of larynx and hypopharynx. Acta Otolaryngol. 2009;129:1480–5.
Johnson LV, Gran C, Overgeard J. Hypopharyngeal Squamous cell carcinoma treatment results in 138 consumptive advised patients. Acta Otolaryngol. 2000;39:529–36.
Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastasis distant metastasis and second primary malignancies in carcinoma of larynx and hypopharynx. Laryngoscope. 2001;111:1079–87.
Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer. Patient care evaluation. Laryngoscope. 1997;107:1005–17.
Combe M, Jones AS. Radiotherapy complications following laryngectomy. J Laryngol Otol. 1993;107:130–2.
Bahadur S, Thakar A, Mohanti BK, Lal P. Results of radiotherapy with or without salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of hypopharynx. J Laryngol Otol. 2002;116:29–32.
Kim S, Wu HG, Heo D, et al. Advanced hypopharynx carcinoma treatment results according to treatment modalities. Head Neck. 2001;23:713–7.
Pingree TF, Davis RK, Richman O, Derrick L. Treatment of hypopharyngeal carcinoma: a 10 year review of 1362 cases. Laryngoscope. 1987;97:901–4.
Kraus DH, Relefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiotherapy for squamous carcinoma of the hypopharynx. Otolaryngol Head Neck Surg. 1997;116:637–41.
Wallberg PC, Anderson KE, Biorklund AT. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30 year period. Head Neck. 1998;20:714–9.
Forastiere AA, Geopfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–8.
Gupta T, Chopra S, Agarwal JP, et al. Squamous cell carcinoma of the hypopharynx single institution outcome analysis of large cohort of patients treated with primary non-surgical approaches. Acta Oncol. 2009;48:541–8.
Eckel HE, Starr S, Volling P, Suttal C, et al. Surgical treatment for hypopharynx carcinoma: feasibility, mortality and results. Otolaryngol Head Neck Surg. 2001;124:561–9.
Lefebvre JL. What is the role of primary surgery in treatment of laryngeal and hypopharyngeal cancer- Harrys- Martin Lecture. Arch Otolaryngol Head Neck Surg. 2000;126:285–588.
The Department of veterans affairs Laryngeal cancer study group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
Lefebvre JL, Rolland F, Tessalar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009;101:142–52.
Pignon JP, Le Maitre A, Maillard E, Bourhis J, MACH-NC collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17346 patients. Radiother Oncol. 2009;92:4–14.
Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for locally advanced larynx and hypopharynx cancer subgroup in Tax 324, survival, surgery and organ preservation. Ann Oncol. 2009;20:921–7.
Rades D, Fehlaur F, Sheikh Sharaf M, et al. Toxicity of two cisplatin-based radio-chemotherapy regimens for treatment of patients with stage III/IV head and neck cancer. Head Neck. 2008;30:235–41.
Zuur CL, Simmis YJ, Lahadaal PE, et al. Risk factors of ototoxicity after cisplatin based chemo-radiation in locally advanced head and neck cancer; a multivariate analysis. Int J Radiat Oncol Biol Phys. 2007;68:1320–5.
Sharma A, Mohanti BK, Thakar A, Bahadur S, Bhaskar S. Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial. Ann Oncol. 2010;21(11):2272–7.
Lee WT, Akst LM, Adelstein DJ, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemo-radiotherapy. Head Neck. 2006;28:808–12.
Vergeer MR, Doornaert PA, Reitveld DH, et al. Intensity induced morbidity and improves health related quality of life: results of a non-randomized prospective study. Int J Radiat Oncol Biol Phys. 2009;74:1–8.
Clark JR, de Almeida J, Gilbert R, et al. Primary and salvage hypopharyngectomy: analysis and outcome. Head Neck. 2006;28:671–7.
Relic A, Sleveict M, Stapf J, et al. Salvage surgery after induction chemotherapy with paclitaxel cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinoma. Ear Arch Otolaryngeal. 2009;206:1799–805.
Davidsom J, Briant D, Gullane P, et al. The role of surgery following radiotherapy failure for advanced laryngopharyngeal cancer. Arch Otolaryngol Head Neck Surg. 1994;120:269–76.
Wang RJ, Shah JP. The role of the head and neck surgeon in contemporary multidisciplinary treatment programme for advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18:79–82.
Pradhan SA, D’Cruz AK, Pai PS, et al. Near total laryngectomy in advanced laryngeal and piriform cancers. Laryngoscope. 2002;112:375–80.
Shenoy AM, Pinkert PK, Nunjundappa N, et al. Functional utility and oncologic safety of near total laryngectomy with trachea-pharyngeal speech shunt in a Third World Oncologic Centre. Eur Arch Otolaryngol. 1997;254:128–32.
Thakar A, Bahadur S, Toran KC, et al. Oncologic and functional failures in near total laryngectomy. Otolaryngol Head Neck Surg. 2007;137:223.
Shah J. Hypopharynx and cervical oesophagus. In: Shah JP, Patel SG, editors. Head and neck surgery and oncology. 3rd ed. Philadelphia: Mosby; 2004. p. 235–66.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Cite this chapter
Bahadur, S. (2019). Guidelines in Management of Carcinoma of the Hypopharynx. In: Bahadur, S., Thakar, A., Mohanti, B. (eds) Carcinoma of the Larynx and Hypopharynx . Springer, Singapore. https://doi.org/10.1007/978-981-13-3110-7_10
Download citation
DOI: https://doi.org/10.1007/978-981-13-3110-7_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3109-1
Online ISBN: 978-981-13-3110-7
eBook Packages: MedicineMedicine (R0)